NGS for precision medicine in non-small cell lung cancer: Challenges and opportunities

被引：2
|
作者：
Mileyko, V. [1 ]
Ivanov, M. [1 ]
Novikova, E. [2 ]
Telysheva, E. [2 ]
Chernenko, P. [3 ]
Breder, V. [3 ]
Laktionov, K. [3 ]
Baranova, A. [4 ]
机构：
[1] Inst Chem Biol & Fundamental Med, Lab Mol Med, Novosibirsk, Russia
[2] Russian Sci Ctr Radiol & Nucl Med, Lab Mol Biol & Cytogenet, Moscow, Russia
[3] NN Blokhin Russian Canc Res Ctr, Dept Clin Biotechnol, Moscow, Russia
[4] George Mason Univ, Sch Syst Biol, Washington, DC USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw363.67
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
119P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Metformin for non-small cell lung cancer patients: Opportunities and pitfalls
    Levy, Antonin
    Doyen, Jerome
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 125 : 41 - 47
  • [42] Management of non-small cell lung cancer in the era of personalized medicine
    Rocco, Gaetano
    Morabito, Alessandro
    Leone, Alessandra
    Muto, Paolo
    Fiore, Francesco
    Budillon, Alfredo
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2016, 78 : 173 - 179
  • [43] KRAS and the Reality of Personalized Medicine in Non-Small Cell Lung Cancer
    Havva O Kilgoz
    Guzide Bender
    Joseph M Scandura
    Agnes Viale
    Bahar Taneri
    Molecular Medicine, 2016, 22 : 380 - 387
  • [44] The Tissue Is the Issue: Personalized Medicine for Non-Small Cell Lung Cancer
    Hirsch, Fred R.
    Wynes, Murry W.
    Gandara, David R.
    Bunn, Paul A., Jr.
    CLINICAL CANCER RESEARCH, 2010, 16 (20) : 4909 - 4911
  • [45] KRAS and the Reality of Personalized Medicine in Non-Small Cell Lung Cancer
    Kilgoz, Havva O.
    Bender, Guzide
    Scandura, Joseph M.
    Viale, Agnes
    Taneri, Bahar
    MOLECULAR MEDICINE, 2016, 22 : 380 - 387
  • [46] Challenges in the Use of Targeted Therapies in Non-Small Cell Lung Cancer
    Rivera-Concepcion, Joel
    Uprety, Dipesh
    Adjei, Alex A.
    CANCER RESEARCH AND TREATMENT, 2022, 54 (02): : 315 - 329
  • [47] Staging of non-small cell lung cancer: consensus, controversies and challenges
    van Meerbeeck, JP
    LUNG CANCER, 2001, 34 : S95 - S107
  • [48] Clinical challenges in neoadjuvant immunotherapy for non-small cell lung cancer
    Guo, Hanfei
    Li, Wenqian
    Qian, Lei
    Cui, Jiuwei
    CHINESE JOURNAL OF CANCER RESEARCH, 2021, 33 (02) : 203 - 215
  • [49] Challenges treating older non-small cell lung cancer patients
    Gridelli, C.
    Rossi, A.
    Maione, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 109 - 113
  • [50] Eribulin in non-small cell lung cancer: challenges and potential strategies
    Swami, Umang
    Shah, Umang
    Goel, Sanjay
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (04) : 495 - 508
12345